Zimbabwe has rejected a proposed US$ 367 million health financing package from the United States, pointing to worries over data sovereignty and what it described as uneven benefit-sharing terms.
The decision came to light after a December government memo was leaked, revealing that President Emmerson Mnangagwa considered the draft agreement skewed against Zimbabwe’s interests.
Following the disclosure, U.S. Ambassador to Zimbabwe Pamela Tremont said Washington would start phasing out health support to the country.
Government spokesperson Nick Mangwana explained that authorities were uneasy about clauses requiring Zimbabwe to grant access to sensitive biological materials without firm assurances that the country would share in any vaccines, diagnostics or treatments developed from that research.
The crux of the disagreement lay in provisions mandating the sharing of biological samples and associated health data for scientific study. Zimbabwean officials argued that the framework failed to guarantee fair returns and pointed to World Health Organization guidelines on pathogen access and benefit-sharing during health emergencies as a benchmark bilateral agreements ought to reflect.
Also Read: Kenyan Banks Enable 24/7 Cross-Border Payments in Local Currencies Under Pesalink
The proposed funding arrangement also unfolded against the backdrop of shifting U.S. foreign aid policy. Since returning to office, President Donald Trump has reduced overseas assistance and shuttered the United States Agency for International Development, favouring direct government-to-government deals to enhance oversight. According to the U.S. embassy, 16 African nations have entered into new health agreements worth more than US$ 18 billion under this revised model.
The Zimbabwe College of Public Health Physicians acknowledged the government’s reservations regarding data governance but called for sustained dialogue to find common ground.